FGF21 and metabolic dysfunction-associated steatotic liver disease: M30 was reported to be more accurate in diagnosing NAFLD than FGF21 in a cross-sectional study16, our current prospective study demonstrated that neither baseline M30 nor M65ED level can independently predict the onset of simple steatosis.